Bank of America’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $796M | Buy |
2,718,766
+511,626
| +23% | +$168M | 0.06% | 287 |
|
|
2025
Q4 | $774M | Sell |
2,207,140
-388,592
| -15% | -$131M | 0.06% | 301 |
|
|
2025
Q3 | $839M | Buy |
2,595,732
+413,143
| +19% | +$128M | 0.06% | 305 |
|
|
2025
Q2 | $849M | Sell |
2,182,589
-22,131
| -1% | -$8.9M | 0.06% | 295 |
|
|
2025
Q1 | $959M | Buy |
2,204,720
+878,855
| +66% | +$353M | 0.08% | 249 |
|
|
2024
Q4 | $489M | Sell |
1,325,865
-853,889
| -39% | -$357M | 0.04% | 381 |
|
|
2024
Q3 | $1.13B | Buy |
2,179,754
+65,159
| +3% | +$34.8M | 0.09% | 221 |
|
|
2024
Q2 | $1.15B | Buy |
2,114,595
+24,555
| +1% | +$13M | 0.1% | 206 |
|
|
2024
Q1 | $1.08B | Buy |
2,090,040
+542,185
| +35% | +$270M | 0.1% | 218 |
|
|
2023
Q4 | $730M | Buy |
1,547,855
+19,899
| +1% | +$9.2M | 0.07% | 267 |
|
|
2023
Q3 | $665M | Sell |
1,527,956
-22,992
| -1% | -$10.4M | 0.07% | 264 |
|
|
2023
Q2 | $689M | Sell |
1,550,948
-1,338,966
| -46% | -$618M | 0.07% | 259 |
|
|
2023
Q1 | $1.33B | Sell |
2,889,914
-380,426
| -12% | -$181M | 0.14% | 158 |
|
|
2022
Q4 | $1.68B | Sell |
3,270,340
-904,802
| -22% | -$459M | 0.19% | 123 |
|
|
2022
Q3 | $1.9B | Sell |
4,175,142
-483,231
| -10% | -$231M | 0.23% | 93 |
|
|
2022
Q2 | $2.25B | Buy |
4,658,373
+131,094
| +3% | +$64.9M | 0.26% | 81 |
|
|
2022
Q1 | $2.22B | Buy |
4,527,279
+1,297,885
| +40% | +$593M | 0.22% | 93 |
|
|
2021
Q4 | $1.5B | Buy |
3,229,394
+84,082
| +3% | +$35.4M | 0.15% | 136 |
|
|
2021
Q3 | $1.17B | Sell |
3,145,312
-610,519
| -16% | -$232M | 0.12% | 163 |
|
|
2021
Q2 | $1.43B | Buy |
3,755,831
+31,812
| +0.9% | +$12.2M | 0.15% | 140 |
|
|
2021
Q1 | $1.34B | Buy |
3,724,019
+118,719
| +3% | +$38.2M | 0.15% | 139 |
|
|
2020
Q4 | $1.16B | Sell |
3,605,300
-45,903
| -1% | -$14.1M | 0.15% | 143 |
|
|
2020
Q3 | $981M | Buy |
3,651,203
+77,163
| +2% | +$20.8M | 0.13% | 146 |
|
|
2020
Q2 | $940M | Buy |
3,574,040
+28,779
| +0.8% | +$7.68M | 0.14% | 146 |
|
|
2020
Q1 | $805M | Buy |
3,545,261
+305,296
| +9% | +$83.2M | 0.15% | 145 |
|
|
2019
Q4 | $979M | Buy |
3,239,965
+535,504
| +20% | +$147M | 0.14% | 158 |
|
|
2019
Q3 | $649M | Buy |
2,704,461
+506,261
| +23% | +$139M | 0.1% | 210 |
|
|
2019
Q2 | $620M | Sell |
2,198,200
-444,166
| -17% | -$121M | 0.09% | 220 |
|
|
2019
Q1 | $758M | Sell |
2,642,366
-437,018
| -14% | -$126M | 0.12% | 183 |
|
|
2018
Q4 | $809M | Buy |
3,079,384
+20,472
| +0.7% | +$5.63M | 0.14% | 159 |
|
|
2018
Q3 | $838M | Buy |
3,058,912
+126,493
| +4% | +$32.8M | 0.13% | 166 |
|
|
2018
Q2 | $698M | Buy |
2,932,419
+254,970
| +10% | +$59M | 0.12% | 194 |
|
|
2018
Q1 | $588M | Buy |
2,677,449
+348,815
| +15% | +$81.9M | 0.1% | 206 |
|
|
2017
Q4 | $524M | Buy |
2,328,634
+865,393
| +59% | +$184M | 0.09% | 238 |
|
|
2017
Q3 | $278M | Sell |
1,463,241
-210,754
| -13% | -$40.1M | 0.04% | 382 |
|
|
2017
Q2 | $315M | Buy |
1,673,995
+245,894
| +17% | +$44.2M | 0.06% | 308 |
|
|
2017
Q1 | $236M | Buy |
1,428,101
+153,580
| +12% | +$24.4M | 0.05% | 366 |
|
|
2016
Q4 | $183M | Sell |
1,274,521
-751,204
| -37% | -$101M | 0.04% | 427 |
|
|
2016
Q3 | $254M | Sell |
2,025,725
-414,508
| -17% | -$53.5M | 0.06% | 328 |
|
|
2016
Q2 | $321M | Buy |
2,440,233
+28,220
| +1% | +$3.86M | 0.07% | 278 |
|
|
2016
Q1 | $335M | Buy |
2,412,013
+731,998
| +44% | +$97.8M | 0.08% | 255 |
|
|
2015
Q4 | $234M | Buy |
1,680,015
+74,586
| +5% | +$10.3M | 0.06% | 349 |
|
|
2015
Q3 | $225M | Buy |
1,605,429
+747,317
| +87% | +$112M | 0.06% | 350 |
|
|
2015
Q2 | $141M | Buy |
858,112
+89,137
| +12% | +$14.2M | 0.05% | 421 |
|
|
2015
Q1 | $119M | Sell |
768,975
-299,038
| -28% | -$42.6M | 0.04% | 448 |
|
|
2014
Q4 | $134M | Buy |
1,068,013
+327,768
| +44% | +$40.5M | 0.05% | 434 |
|
|
2014
Q3 | $88.5M | Sell |
740,245
-175,434
| -19% | -$20.1M | 0.03% | 586 |
|
|
2014
Q2 | $98.5M | Buy |
915,679
+471,992
| +106% | +$48.6M | 0.03% | 546 |
|
|
2014
Q1 | $44.2M | Sell |
443,687
-40,657
| -8% | -$3.68M | 0.02% | 818 |
|
|
2013
Q4 | $44.7M | Sell |
484,344
-78,777
| -14% | -$7M | 0.02% | 810 |
|
|
2013
Q3 | $47.1M | Buy |
563,121
+470
| +0.1% | +$40.3K | 0.02% | 765 |
|
|
2013
Q2 | $46M | Buy |
+562,651
| New | +$42.1M | 0.02% | 736 |
|
Other funds holding ELV
VCM
VPM
Bank of America's ELV Position: Q1 2026 in Review
Bank of America increased its Elevance Health (ELV) stake by 23% in Q1 2026, buying an estimated $168M and bringing the position to 2,718,766 shares worth $796M. The position accounts for 0.06% of the portfolio, ranked #287.
Bank of America first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.25B in Q2 2022. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Bank of America held 2,718,766 shares of Elevance Health worth $796M as of Q1 2026.
- Bank of America bought 511,626 Elevance Health shares in Q1 2026, an estimated $168M.
- Elevance Health made up 0.06% of Bank of America's portfolio in Q1 2026, its #287 holding.
- Bank of America first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Elevance Health position peaked at $2.25B in Q2 2022.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.